Pathstone Holdings
BNTX icon

Pathstone Holdings’s BioNTech BNTX Stock Holding History

Pathstone Holdings’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,501
Closed -$285K – 2267
2024
Q4 		$285K Sell
2,501
-1,091
-30% -$125K ﹤0.01% 1993
2024
Q3 		$427K Sell
3,592
-120
-3% -$11K ﹤0.01% 1805
2024
Q2 		$298K Sell
3,712
-388
-9% -$35.5K ﹤0.01% 1941
2024
Q1 		$378K Buy
4,100
+1,379
+51% +$132K ﹤0.01% 1813
2023
Q4 		$287K Buy
+2,721
New +$274K ﹤0.01% 1860

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Pathstone Holdings's BNTX Position: Q1 2025 in Review

Pathstone Holdings sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 2,501 shares — an estimated $285K sold.

Pathstone Holdings first reported a position in BNTX in Q4 2023 and held it in 5 quarters. The position peaked at $427K in Q3 2024. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

  • Pathstone Holdings reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
  • Pathstone Holdings sold 2,501 BioNTech shares in Q1 2025, an estimated $285K.
  • Pathstone Holdings first reported a position in BioNTech in Q4 2023 and held it in 5 quarters.
  • Pathstone Holdings's BioNTech position peaked at $427K in Q3 2024.
  • 280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on Pathstone Holdings's 13F filing for Q1 2025, filed 15 May 2025.